These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20635947)

  • 1. Immunotherapeutic polyoma and human papilloma virus-like particles.
    Ramqvist T; Dalianis T
    Immunotherapy; 2009 Mar; 1(2):303-12. PubMed ID: 20635947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
    Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
    Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.
    Hindmarsh PL; Laimins LA
    Virol J; 2007 Feb; 4():19. PubMed ID: 17324266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice.
    Voronkova T; Grosch A; Kazaks A; Ose V; Skrastina D; Sasnauskas K; Jandrig B; Arnold W; Scherneck S; Pumpens P; Ulrich R
    Viral Immunol; 2002; 15(4):627-43. PubMed ID: 12513932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors.
    Tegerstedt K; Lindencrona JA; Curcio C; Andreasson K; Tullus C; Forni G; Dalianis T; Kiessling R; Ramqvist T
    Cancer Res; 2005 Jul; 65(13):5953-7. PubMed ID: 15994974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
    Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
    Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of the hamster polyomavirus major capsid protein VP1.
    Siray H; Frömmel C; Voronkova T; Hahn S; Arnold W; Schneider-Mergener J; Scherneck S; Ulrich R
    Viral Immunol; 2000; 13(4):533-45. PubMed ID: 11192300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
    Pinto LA; Edwards J; Castle PE; Harro CD; Lowy DR; Schiller JT; Wallace D; Kopp W; Adelsberger JW; Baseler MW; Berzofsky JA; Hildesheim A
    J Infect Dis; 2003 Jul; 188(2):327-38. PubMed ID: 12854090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
    Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
    Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chimpanzee polyomavirus-specific antibodies in captive and wild-caught chimpanzees using yeast-expressed virus-like particles.
    Zielonka A; Verschoor EJ; Gedvilaite A; Roesler U; Müller H; Johne R
    Virus Res; 2011 Feb; 155(2):514-9. PubMed ID: 21187117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.